SB-683699

· GlaxoSmithKline

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SB-683699, covering 2012-04-09 to 2012-04-09. Get the full timeline:

Most recent: Clinical Trial Update: Study Of SB-683699 Compared To Placebo In Subjects With Relapsing-Remitting Multiple Sclerosis (MS) [Phase 2]